AptamiR Therapeutics
PrivateLast Round
Seed
Sep 21, 2015
Total Funding Raised
$3M
Company Overview
AptamiR Therapeutics operates in Healthcare & Life Sciences and is based in Naples, Florida. Its latest recorded funding round was a Seed round in September 2015.
AptamiR Therapeutics is a biotechnology company that develops microRNA-based oligonucleotide therapeutics to treat cardiometabolic disorders and ovarian cancer.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Drug Discovery, Precision Medicine
Business Model
B2B
Customer Profile
Revenue Share, Services & Consulting, Government Contracts
AI Layer
Non-AI
Historical Pricing
Historical view of private secondary pricing and transaction trends.
AptamiR Therapeutics Comparables
Compare AptamiR Therapeutics with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| Resalis Therapeutics | 86% | |
| Novo Nordisk | 73% | |
| miRecule, Inc. | 71% |
For institutional investors. Book with your work email.
AptamiR Therapeutics Funding Rounds
Historical fundraising activity
For institutional investors. Book with your work email.
AptamiR Therapeutics Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| Austin Technology Incubator | Seed, Accelerator |
Market signals
Structured signals derived from secondary market and firmographic data.
- Sep 21, 2015
$3M raised with Austin Technology Incubator participating.
For institutional investors. Book with your work email.
AptamiR Therapeutics Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Book a demoFor institutional investors. Book with your work email.
Frequently Asked Questions
Common questions about AptamiR Therapeutics's valuation, stock price, and market status.
Is AptamiR Therapeutics a public or private company?
AptamiR Therapeutics is a private company.
What is the current stock price of AptamiR Therapeutics?
AptamiR Therapeutics is a private company, so its shares have no public market price. Caplight tracks AptamiR Therapeutics's secondary market activity and provides MarketPrice™ estimates of its share price to Caplight users.
How much is AptamiR Therapeutics worth (valuation)?
Valuation information for AptamiR Therapeutics is not publicly available.
Can I buy AptamiR Therapeutics stock?
AptamiR Therapeutics shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors.
When was AptamiR Therapeutics's last funding round?
AptamiR Therapeutics's most recent funding round was Seed on September 21, 2015.
Who are the main investors in AptamiR Therapeutics?
Key investors in AptamiR Therapeutics include Austin Technology Incubator.
Will AptamiR Therapeutics IPO soon?
No public IPO plans have been announced for AptamiR Therapeutics.
How can I track AptamiR Therapeutics secondary market activity?
Caplight tracks bids, offers, and trades in AptamiR Therapeutics's shares on secondary markets.